PUBLIC COMPANY
save$CGENCOMPUGEN LTD
$CGENHolon, ILupdated 4mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer
- phase1A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
- phase1COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies
- phase1COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
- phase2COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.
Insider activity
source: SEC Form 4open-market buys + sells
routine RSU / option mechanics (6)
- Apr 14, 26option exerciseOphir Eran · President and CEO5,000 sh
- Apr 14, 26option exerciseLevine Zurit · SVP, Business Development2,000 sh
- Apr 14, 26option exerciseLevine Zurit · SVP, Business Development2,000 sh
- Apr 14, 26option exerciseOphir Eran · President and CEO5,000 sh
- Apr 10, 26option exerciseLevine Zurit · SVP, Business Development2,000 sh
- Apr 10, 26option exerciseLevine Zurit · SVP, Business Development1,125 sh
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 14m ago
Found something off?
comments(0)
5-min edit window · permanent after that